NEOGENOMICS INC·4

Feb 24, 4:15 PM ET

Stone Warren 4

4 · NEOGENOMICS INC · Filed Feb 24, 2026

Research Summary

AI-generated summary of this filing

Updated

NeoGenomics (NEO) COO Stone Warren Converts/Exercises Derivatives

What Happened

  • Stone Warren, President & Chief Operating Officer (reported as COO), converted/exercised a total of 36,548 derivative awards (28,105 shares on Feb 21, 2026 and 8,443 shares on Feb 23, 2026). The reported dollar price for these entries is $0.00, indicating conversion/vesting rather than an open-market purchase.
  • To satisfy tax withholding obligations, 10,465 shares were withheld by the issuer (7,142 on Feb 21 and 3,323 on Feb 23). After withholding, Warren’s net increase in beneficially owned shares from these transactions is 26,083 shares.
  • These transactions appear to be award conversions/vestings with share withholding for taxes (routine), not open-market sales.

Key Details

  • Transaction dates: Feb 21, 2026 and Feb 23, 2026 (reported on Form 4 filed Feb 24, 2026). Filing appears timely.
  • Reported prices: $0.00 for all entries (conversion/vesting or non-cash exercise events).
  • Shares acquired (gross): 36,548; shares disposed (withheld for taxes): 10,465; net +26,083 shares.
  • Notable footnotes: F1 explains restricted stock units convert into common stock on vesting; F2 confirms the dispositions were withholding to satisfy tax obligations. Additional footnotes (F3, F16, F18, F19, etc.) describe prior grants and modified vesting schedules after promotion.
  • Shares owned after the transaction: not provided in the excerpt.

Context

  • M = exercise or conversion of a derivative; F = disposition to satisfy tax withholding. Here, "exercise/conversion" likely reflects RSU/award vesting or conversion of derivative awards into common stock, with shares withheld to cover taxes (a routine administrative action).
  • Because the transactions were internal conversions and withholding (reported at $0), they are not the same as an open-market purchase (which might be viewed as a bullish signal) nor a sale of shares to obtain cash.
  • These filings are factual records of award vesting/conversion and tax withholding; they do not, by themselves, indicate the officer's view of the company's stock.

Insider Transaction Report

Form 4
Period: 2026-02-21
Stone Warren
Pres & Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-21+28,105149,736 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-217,142142,594 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-23+8,443151,037 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-233,323147,714 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F3][F4]
    2026-02-2128,10556,212 total
    Exercise: $0.00Common Stock (28,105 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F5][F4]
    2026-02-238,4438,443 total
    Exercise: $0.00Common Stock (8,443 underlying)
Holdings
  • Stock Option (Right to Buy)

    [F6]
    Exercise: $11.21Exp: 2029-12-01Common Stock (166,113 underlying)
    166,113
  • Stock Option (Right to Buy)

    [F7]
    Exercise: $19.65Exp: 2030-05-11Common Stock (53,969 underlying)
    53,969
  • Performance Stock Unit

    [F8][F4]
    Exercise: $0.00From: 2026-05-11Common Stock (21,204 underlying)
    21,204
  • Restricted Stock Unit

    [F9][F4]
    Exercise: $0.00Common Stock (9,613 underlying)
    9,613
  • Stock Option (Right to Buy)

    [F10]
    Exercise: $16.45Exp: 2034-02-23Common Stock (42,344 underlying)
    42,344
  • Performance Stock Unit

    [F11][F4]
    Exercise: $0.00From: 2027-02-23Common Stock (25,330 underlying)
    25,330
  • Stock Option (Right to Buy)

    [F12]
    Exercise: $13.96Exp: 2034-05-02Common Stock (29,976 underlying)
    29,976
  • Restricted Stock Unit

    [F13][F4]
    Exercise: $0.00Common Stock (17,908 underlying)
    17,908
  • Performance Stock Unit

    [F14][F4]
    Exercise: $0.00From: 2027-05-02Common Stock (17,908 underlying)
    17,908
  • Restricted Stock Unit

    [F4]
    Exercise: $0.00From: 2026-01-13Common Stock (59,382 underlying)
    59,382
  • Stock Option (Right to Buy)

    [F15][F16]
    Exercise: $13.05Exp: 2035-02-21Common Stock (143,266 underlying)
    143,266
  • Stock Option (Right to Buy)

    [F17][F18]
    Exercise: $10.44Exp: 2035-04-01Common Stock (94,518 underlying)
    94,518
  • Restricted Stock Unit

    [F19][F4]
    Exercise: $0.00Common Stock (52,687 underlying)
    52,687
Footnotes (19)
  • [F1]Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
  • [F10]On February 23, 2024, Mr. Stone was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.
  • [F11]On February 23, 2024, Mr. Stone was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
  • [F12]On May 2, 2024, Mr. Stone was granted 29,976 stock options. The options vest ratably over the first three anniversary dates of the grant date.
  • [F13]On May 2, 2024, Mr. Stone was granted 17,905 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
  • [F14]On May 2, 2024, Mr. Stone was granted 17,908 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is26,862. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
  • [F15]This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
  • [F16]On February 21, 2025, Mr. Stone was granted 143,266 stock options. At the time of the grant, the options vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone's promotion to President &Chief Operating Officer on April 1, 2025, the vesting schedule of these options was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.
  • [F17]This stock option was granted as a premnium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.
  • [F18]On April 1, 2025, Mr. Stone was granted 94,518 stock options. The options vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.
  • [F19]On April 1, 2025, Mr. Stone was granted 52,687 restricted stock units. The restricted stock units vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.
  • [F2]Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
  • [F3]On February 21, 2025, Mr. Stone was granted 84,317 restricted stock units. At the time of the grant, the restricted stock units vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone'spromotion to President & Chief Operating Officer on April 1, 2025, the vesting schedule of these restricted stock units was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grantdate.
  • [F4]Once vested, the shares of common stock are not subject to expiration.
  • [F5]On February 23, 2024, Mr. Stone was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
  • [F6]On December 1, 2022, Mr. Stone was granted 166,113 stock options. The options vest ratably over the first four anniversary dates of the grant date.
  • [F7]On May 11, 2023, Mr. Stone was granted 53,969 stock options. The options vest ratably over the first three anniversary dates of the grant date.
  • [F8]On May 11, 2023, Mr. Stone was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is31,806. The number of performance stock units that may vest is based on the achievement of certain growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company.
  • [F9]On May 11, 2023, Mr. Stone was granted 28,838 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
Signature
/s/ Ali Olivo, Attorney-in-Fact|2026-02-24

Documents

1 file
  • 4
    wk-form4_1771967722.xmlPrimary

    FORM 4